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Abstract
This review emphasizes the benefits of parenteral nutrition (PN) in critically ill patients, when prescribed for relevant
indications, in adequate quantities, and in due time.
Critically ill patients are at risk of energy deficit during their ICU stay, a condition which leads to unfavorable
outcomes, due to hypercatabolism secondary to the stress response and the difficulty to optimize feeding. Indirect
calorimetry is recommended to define the energy target, since no single predictive equation accurately estimates
energy expenditure. Energy metabolism is intimately associated with protein metabolism. Recent evidence calls for
adequate protein provision, but there is no accurate method to estimate the protein requirements, and
recommendations are probably suboptimal. Enteral nutrition (EN) is the preferred route of feeding, but
gastrointestinal intolerance limits its efficacy and PN allows for full coverage of energy needs.
Seven recent articles concerning PN for critically ill patients were identified and carefully reviewed for the clinical
and scientific relevance of their conclusions. One article addressed the unfavorable effects of early PN, although
this result should be more correctly regarded as a consequence of glucose load and hypercaloric feeding. The six
other articles were either in favor of PN or concluded that there was no difference in the outcome compared with
EN. Hypercaloric feeding was not observed in these studies. Hypocaloric feeding led to unfavorable outcomes. This
further demonstrates the beneficial effects of an early and adequate feeding with full EN, or in case of failure of EN
with exclusive or supplemental PN.
EN is the first choice for critically ill patients, but difficulties providing optimal nutrition through exclusive EN are
frequently encountered. In cases of insufficient EN, individualized supplemental PN should be administered to
reduce the infection rate and the duration of mechanical ventilation. PN is a safe therapeutic option as long as
sufficient attention is given to avoid hypercaloric feeding.
Introduction
Providing nutrition to critically ill patients has long been
challenging, due to the difficulties in determining the
nutrition requirements of the patients with heterogeneous
characteristics, and selecting the timing and the route of
administration. Many investigators have tackled these
issues in the form of clinical trials, and guidelines have
been created by experts to aid clinicians in making these
critical decisions [1,2]. However, these guidelines and
recommendations have significantly changed over time
due to conflicting and sometimes misleading study results.
The lack of robust evidence has created numerous con-
troversies regarding the best way of providing nutrition
in critically ill patients [3]. Enteral nutrition (EN) has
been recommended as the first choice of nutritional sup-
port for critically ill patients [2,4]. Recently, a few voices
have suggested that parenteral nutrition (PN) was poten-
tially dangerous for the critically ill patient [5]. In clinical
practice, EN is not always well tolerated due to gastroin-
testinal intolerance. This leads to a massive energy
deficit - that is, the shortfall of energy provision com-
pared with the actual energy needs - by the end of the
patient’s ICU stay, a condition correlated to poor clinical
outcome. This intolerance to EN is of variable amplitude,
and if serious becomes an indication for PN which allows
for full coverage of energy needs.
Recent studies have focused on this problem and have
provided new insights into the practical use of PN. This
article aims at drawing the attention of ICU professionals
to the benefits of a personalized prescription of PN,
which requires optimizing the amount of energy and pro-
tein provision, as well as the timing of administration.
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Limitations of enteral nutrition
Although strongly recommended in recent guidelines,
optimal nutrition for critically ill patients through the
enteral route is nonetheless difficult in some patients
because gastrointestinal tolerance limits the rate of
administration and absorption. For instance, diarrhea is
commonly observed in critically ill patients and is
strongly associated with antibiotic treatment, as well as
with EN administration if covering more than 60% of
the energy needs [6]. Absorption of glucose from EN is
impaired as much as three times in critically ill patients
[7]. These conditions frequently limit the prescription of
full and efficient EN. Nutrients administered by EN
must be digested, a process that increases the energy
and oxygen demand of the intestine, which in turn
increases the splanchnic blood flow [8]. This effect may
be poorly tolerated by hemodynamically compromised
patients. In such cases, exclusive PN [9] or supplemental
parenteral nutrition (SPN) added to a reduced volume
of EN for less critical situations may be valuable thera-
peutic options (Table 1, 2) [10,11].
Parenteral nutrition: the latest studies
In 2014, two large prospective studies challenged the
negative opinions against PN (Table 3). Harvey et al.
[12] compared the results of administering nutrition
either enterally or parenterally. They randomized
patients who would have tolerated EN to receive either
EN or PN. No significant differences in clinical out-
comes (mortality, infection rate) were observed between
the two study groups. However, it should be noted that
this calories trial was conducted under a local audit,
implying a limited external validity. Doig et al. [9] stu-
died patients with relative contraindications to EN, who
received PN early or late during the course of their ICU
stay. The study design is remarkable because it truly
reflects the daily practice. The results were in favor of
the early PN strategy with a significant reduction in
days on ventilators without an effect on mortality,
although the actual difference was limited (-0.047 days
per 10 patient-ICU-days).
These studies, added to other prospective randomized
controlled trials (PRCTs) (Table 3), demonstrate that
PN is safe, and should be regarded as an alternative
treatment in the case of contraindication or poor toler-
ance to EN.
Rationale for prescribing nutrition in ICU patients
Severe stress is a physiological response to critical ill-
nesses, and energy is utilized for a variety of reactions
needed for survival. Hypermetabolism is induced by sig-
nals from stress hormones, inflammatory cytokines, and
other mediators [13]. To meet the energy demand
related to hypermetabolism, the body turns to its endo-
genous energy sources, namely glucose by gluconeogen-
esis in the liver and free fatty acids by lipolysis in the
adipocytes. Plasma amino acids generated from
increased skeletal muscle proteolysis also contribute to
glucose production in the liver. This process is not
reversed by exogenous nutrition whatever the composi-
tion, as demonstrated by Tappy et al. [14] who com-
pared the effect of energy provision by isoenergetic PN,
either with a glucose-rich formula or a lipid-rich for-
mula. The use of the glucose-rich formula resulted in an
Table 1. Benefits and risks of parenteral and enteral nutrition
Parenteral nutrition Enteral nutrition
Benefits • Can be administered regardless of gut function • Preserves gut mucosa and function
• Composition of formula can be modified according to patient needs • More physiologic, less invasive
Risks • Invasive procedure needed for administration • Gut function limits rate and amount of administration
• Greater risk of hyperglycemia and overfeeding • Difficult to modify composition of formula
Table 2. Suggested Indications for Parenteral Nutrition
• Prolonged ileus > 3 days
mechanical obstruction, generalized peritonitis, peritoneal carcinosis, abdominal distension on enteral nutrition
• Short Bowel syndrome
mesenteric infarction, extensive small bowel resection
• Severe malabsorption
radiation injury to intestine, high output fistulae, inflammatory bowel diseases in acute phase, splanchnic ischemia
• Time to reach full enteral nutrition or oral > 5 days
• Insufficient energy intakes
• Hyperemesis gravidarum
• High risk of aspiration
Adapted from [11]
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elevation of the oxidation of glucose and de novo lipo-
genesis, while the endogenous glucose production was
not changed by the type of formula. Under normal con-
ditions, amino acids in the plasma act as signals to sti-
mulate anabolism of skeletal muscle. In critically ill
patients, however, due to the signaling from inflamma-
tory mediators and stress hormones, the anabolic signal
of increased plasma amino acids is blunted. Providing
proteins or amino acids stimulates protein synthesis to
some extent but does not stop catabolism [15]. This
phenomenon, termed anabolic resistance, is also a com-
mon metabolic alteration observed during the acute
phase of critical illness [16,17].
Nutritional deficits and clinical outcome
Owing to the elevated demand for energy and difficulties
in providing adequate nutrition, critically ill patients fre-
quently develop a negative energy balance [18]. In addi-
tion, commercial nutrition mixtures are low in protein
and critically ill patients are consequently at risk of devel-
oping a cumulative deficit of energy and protein during
their ICU stay. Such a deficit further aggravates the dele-
terious impact of critical illness on the lean body mass.
Conversely, optimal provision of energy reduces protein
catabolism from the skeletal muscle, whereas protein
provision primarily improves the rate of protein synthesis
in rapidly turning over tissues [19]. Protein-rich nutrition
in the early phase of critical illness may be considered a
strategy capable of modulating the systemic inflammatory
response, while supporting the needed protein synthesis
that takes place during this response [20].
Alberda et al. [21] observed in their study that simply
increasing nutrition support in the early phase of the
ICU stay to minimize the protein-energy deficit improved
clinical outcomes. On the other hand, energy deficits
have been shown to increase the risk of infectious com-
plications and unfavorable clinical outcomes. Faisy et al.
[22] demonstrated that early ICU energy deficit is an
independent determinant for acquiring Staphylococcus
aureus ventilation-associated pneumonia in patients on
prolonged mechanical ventilation. This result was sup-
ported by Ekpe et al. [23], who showed that methicillin-
resistant S. aureus (MRSA) bloodstream infections were
associated with a higher energy deficit than other
ICU-acquired bacteremia. The detrimental effects of
undernutrition have been repeatedly reported during the
last decades and the recent PRCTs have stimulated
experts on both sides of the oceans to recommend the
provision of timely and optimal nutrition during critical
illness.
Defining the needs for energy and protein
Current guidelines call for an early initiation of nutri-
tion, but the recommendations for the use of PN are
conflicting. The European Society for Clinical Nutrition
and Metabolism (ESPEN) guidelines call for EN or PN
within 24-48 hours after admission, with the energy pro-
vision target as close as possible to the measurement by
indirect calorimetry, or 20 kcal/kg/day initially followed
by 25 kcal/kg body weight/day after the acute phase
when indirect calorimetry is unavailable. The target
should be reached within 2-3 days [1]. The American
guidelines - that is a joint recommendation by the
American Society for Parenteral and Enteral Nutrition
(A.S.P.E.N.) and Society of Critical Care Medicine
(SCCM) [2] - and the Canadian Critical Care Practice
Guidelines (CCPGs) [24] call for an early initiation of
EN, but PN should be withheld until 5-7 days [2]. This
difference in the recommendations may have significant
impact on the early achievement of energy targets, espe-
cially when EN is not indicated or poorly tolerated.
Energy targets are usually based on predictive equations.
There are over 200 equations to estimate patients’ meta-
bolic rates, but only a few are applicable during critical ill-
ness [25]. Clinicians turn to these equations largely due to
the lack of reliable indirect calorimeters on the market.
However, there is no single predictive equation that is
accurate during critical illness due to the great heterogene-
ity of pathologies and treatments [26]. McClave et al. [27]
reported that, compared with the measurements by indir-
ect calorimetry, energy expenditure (EE) estimation based
on predictive equations was inaccurate for nearly 70% of
the critically ill patients (Figure 1). As a result, only about
25% of the patients received an energy provision within
10% of the measured EE [27]. Indirect calorimetry is thus
recommended for all critically ill patients for an adequate
determination of the energy target.
The importance of protein provision has recently
drawn more attention. Unlike energy, there is no speci-
fic method to measure the protein need in a timely
manner at the bedside. Ishibashi et al. [28] suggested
that body protein catabolism over a 10-day period after
ICU admission was reduced by 50% when protein intake
increased and allowed a reduction of muscle loss of 1.1-
1.5 g/kg dry fat-free mass/day. Current trend among
experts is to increase intakes up to 1.5-1.8 g/kg/day and
consider the protein/energy ratio to optimize the simul-
taneous amount of protein and energy to be adminis-
tered. This idea is based on the phenomenon that
energy is needed for protein efficacy [29]. Berg et al.
[30] compared the whole-body kinetics during hypocalo-
ric feeding (50% EE measured by indirect calorimetry)
and full feeding (100% EE) in critically ill patients.
Whole-body protein synthesis was lower during hypoca-
loric feeding while whole-body protein degradation was
unaltered, which resulted in a more negative protein
balance (-1.9 ± 2.1 vs. -0.7 ± 1.3 mg phenylalanine/kg/
hour, p = 0.014).
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A number of studies have investigated the effects of
PN, to achieve energy and protein goals at different tim-
ings after ICU admission [31]. Casaer et al. [5] analyzed
the impact of an early systematic administration of PN
on day 3 after ICU admission, preceded by massive glu-
cose load (400 and 800 kcal during the first 2 days), ver-
sus a late initiation of PN on day 8, after 7 days of
underfeeding. Tight glycemic control, nowadays shown
to be deleterious, was applied to all patients. They found
no difference in mortality, but fewer infections, a higher
degree of acute inflammation, and shorter duration of
mechanical ventilation were observed in the late initia-
tion group. These results were misinterpreted when stat-
ing that early PN is harmful for critically ill patients,
while relative overfeeding as a result of excessive energy
administration by PN in addition to the noninhibitable
endogenous energy production is more likely to be the
cause of unfavorable outcome. Overfeeding resulted in
increased insulin needs to achieve glycemia control in
Casaer et al.’s study, in which the patients in the early PN
group needed nearly double the amount of insulin for
this purpose as shown in the late PN group. These results
also emphasize the importance of a precise determination
of the energy target, which is only possible with indirect
calorimetry.
Heidegger et al. [10] studied the effect of SPN by ran-
domizing patients who were given less than 60% of pre-
scribed energy on the third ICU day to receive either
SPN or continue solely on EN (Table 3). Significant
reduction (p = 0.03) in the rate of late nosocomial infec-
tions until 28 days after ICU admission and of antibiotic
days per patient, resulting in more antibiotic-free days,
was observed in patients who were given SPN to meet
energy targets determined by indirect calorimetry, while
there were no differences in the mortality or the length
of stay in the ICU. Of importance, there was no differ-
ence in the number of bloodstream infections in the
SPN group versus the EN-only group.
Petros et al. [32] compared critically ill patients who
were given nutrition for more than 3 days with energy
targets of 50% EE (hypocaloric feeding) and 100% EE
(normocaloric feeding). The normocaloric group suf-
fered fewer nosocomial infections (11.6%) compared
with the hypocaloric group (26.1%, p = 0.046).
Weijs et al. [33] studied mechanically ventilated criti-
cally ill patients who were given nutrition according to
indirect calorimetry and a protein target of 1.2 g/kg
body weight. Optimal provision of both protein and
energy was associated with a 50% decrease in 28-day
mortality, where only reaching energy targets did not
reduce mortality. The results of this study, which
addressed the importance of both energy and protein,
were further supported by Allingstrup et al. [34]. They
demonstrated in an observational study of mixed criti-
cally ill patients that only patients receiving a protein
delivery >1 g/kg/day had a reduced mortality, regardless
of adequate energy delivery. All of these studies support
the use of PN for the critically ill patients, provided that
they are closely monitored to avoid both hypercaloric
and hypocaloric feeding.
Perspectives
Growing evidence suggests the benefits of providing per-
sonalized provision of energy and protein while avoiding
both hypocaloric and hypercaloric feeding. To achieve
this goal in patients with enteral intolerance or insuffi-
ciency, PN under careful monitoring techniques is a
relevant and practical solution. Indirect calorimetry is
recommended for all critically ill patients, to measure
their energy requirements and to monitor metabolic
changes during the course of critical illness. Currently,
the availability and accuracy of indirect calorimetry is
Figure 1 Distribution of the metabolic state of critically ill
patients. Measured energy expenditure (EE) by indirect calorimetry
was compared with estimated EE by the Harris-Benedict (H-B)
equation in 213 critically ill patients. “Normal metabolism” represents
those patients with measured EE within 10% of the estimation by
the H-B equation. Those patients exceeding 110% and falling short
of 90% of the estimated EE were categorized as “hypermetabolic”
and “hypometabolic”, respectively. Only 31% of the patients had
normal metabolism, demonstrating the importance of indirect
calorimetry for the accurate assessment of the metabolic state in
critically ill patients. Adapted from [27]
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limited [35,36]. An international initiative supported by
two European academic societies (European Society for
Intensive Care Medicine (ESICM) and ESPEN) is pre-
sently developing an accurate, easy-to-use, and affordable
calorimeter to promote a wider use of this technique.
Methods to measure the protein requirements and to
correctly assess the result of protein and amino acid pro-
vision are needed for the better fine-tuning of protein
provision. There are also new possibilities for the use of
PN. Pradelli et al. [37] showed in a large multisite study
the benefits of providing immune-modulating lipids
using PN. This and other new ideas that may arise must
be studied with careful scientific and clinical logic to
avoid misinterpreted and misleading ideas from interfer-
ing with the progress of patient care.
Conclusion
PN has been regarded as harmful to critically ill patients,
although this conception was not necessarily based on
appropriate scientific or clinical logic. The current
recommendation of nutrition for the critically ill patients
is first to avoid both hypocaloric and hypercaloric feed-
ing. The same attention should also be given to the ade-
quate provision of protein. EN is the first choice for
critically ill patients, but it is frequent to encounter diffi-
culties providing optimal nutrition through exclusive EN.
In the case of insufficient EN, individualized supplemen-
tal PN should be administered to reduce the infection
rate and the duration of mechanical ventilation. PN is a
safe therapeutic option as long as sufficient attention is
given to avoid hypercaloric feeding (Table 4).
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